A Peptide Inhibitor of FOXP3 Impairs Regulatory T Cell Activity and Improves Vaccine Efficacy in Mice

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Immunology

• Publication date

  2010-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.1001114PMID 20870946
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transcriptional regulation of Foxp3 gene: Multiple signal pathways on the road

  2009cited by this paper
• Interactions among the transcription factors Runx1, RORγt and Foxp3 regulate the differentiation of interleukin 17–producing T cells

  2008cited by this paper
• Isoform-specific inhibition of ROR alpha-mediated transcriptional activation by human FOXP3.

  2008cited by this paper
• TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function

  2008cited by this paper
• In Vitro and In Vivo Down-Regulation of Regulatory T Cell Activity with a Peptide Inhibitor of TGF-β11

  2008cited by this paper
• Isoform-Specific Inhibition of RORα-Mediated Transcriptional Activation by Human FOXP31

  2008cited by this paper
• Identification of peptide inhibitors of transforming growth factor beta 1 using a phage-displayed peptide library.

  2007cited by this paper
• Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells

  2007cited by this paper
• Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3

  2007cited by this paper
• Regulatory T-cell inhibition versus depletion: the right choice in cancer immunotherapy

  2007cited by this paper
• Eradication of large tumors in mice by a tritherapy targeting the innate, adaptive, and regulatory components of the immune system.

  2007cited by this paper
• Cell Penetrating Peptides: Intracellular Pathways and Pharmaceutical Perspectives

  2007cited by this paper
• Upregulation of Indoleamine 2,3-Dioxygenase in Hepatitis C Virus Infection

  2007cited by this paper
• FOXP3 is a homo-oligomer and a component of a supramolecular regulatory complex disabled in the human XLAAD/IPEX autoimmune disease.

  2007cited by this paper
• Induction of immunosuppressive molecules and regulatory T cells counteracts the antitumor effect of interleukin-12-based gene therapy in a transgenic mouse model of liver cancer.

  2007cited by this paper
• Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease

  2007influential reference
• Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients

  2007cited by this paper
• FOXP3: Not just for regulatory T cells anymore

  2007cited by this paper
• Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1

  2007cited by this paper
• Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression

  2007cited by this paper
• FOXP3 controls regulatory T cell function through cooperation with NFAT.

  2006cited by this paper
• Assigning the phenotype of a natural regulatory T-cell to the human T-cell line, KARPAS-299.

  2006cited by this paper
• A denileukin diftitox (Ontak) associated retinopathy?

  2006cited by this paper
• Analysis of FOXP3 Reveals Multiple Domains Required for Its Function as a Transcriptional Repressor1

  2006cited by this paper
• Molecular Mechanisms Underlying FOXP3 Induction in Human T Cells1

  2006cited by this paper
• T Cells with a CD4+CD25+ Regulatory Phenotype Suppress In Vitro Proliferation of Virus-Specific CD8+ T Cells during Chronic Hepatitis C Virus Infection

  2005cited by this paper
• Inability of a Fusion Protein of IL-2 and Diphtheria Toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to Eliminate Regulatory T Lymphocytes in Patients With Melanoma

  2005cited by this paper
• Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells.

  2005cited by this paper
• Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma.

  2005cited by this paper
• Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells.

  2005cited by this paper
• An immunomodulatory role for CD4+CD25+ regulatory T lymphocytes in hepatitis C virus infection

  2004cited by this paper
• Foxp3 Expressing CD4+CD25high Regulatory T Cells Are Overrepresented in Human Metastatic Melanoma Lymph Nodes and Inhibit the Function of Infiltrating T Cells1

  2004cited by this paper
• Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

  2004cited by this paper
• Human CD4+ CD25+ Regulatory T Cells Control T-Cell Responses to Human Immunodeficiency Virus and Cytomegalovirus Antigens

  2004cited by this paper
• Neonates support lymphopenia-induced proliferation.

  2003cited by this paper
• Synergistic effect of metronomic dosing of cyclophosphamide combined with specific antitumor immunotherapy in a murine melanoma model.

  2003cited by this paper
• CD4 /CD25 Regulatory Cells Inhibit Activation of Tumor-Primed CD4 T Cells with IFN- -Dependent Antiangiogenic Activity, as well as Long-Lasting Tumor Immunity Elicited by Peptide Vaccination

  2003cited by this paper
• Hepatitis C Virus Structural Proteins Impair Dendritic Cell Maturation and Inhibit In Vivo Induction of Cellular Immune Responses

  2003cited by this paper
• CD4+/CD25+ Regulatory Cells Inhibit Activation of Tumor-Primed CD4+ T Cells with IFN-γ-Dependent Antiangiogenic Activity, as well as Long-Lasting Tumor Immunity Elicited by Peptide Vaccination 1

  2003cited by this paper
• Prevalence of Regulatory T Cells Is Increased in Peripheral Blood and Tumor Microenvironment of Patients with Pancreas or Breast Adenocarcinoma1

  2002cited by this paper
• Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus.

  2002cited by this paper
• Cutting Edge: Depletion of CD4+CD25+ Regulatory T Cells Is Necessary, But Not Sufficient, for Induction of Organ-Specific Autoimmune Disease

  2002cited by this paper
• Certified Professionals

  2001cited by this paper
• Topoisomerase I Inhibitors with an Indolocarbazole Structure Transporter as a Transporter of NB-506 and J-107088 , Resistance / Placenta-Specific , ATP-binding Cassette Identification of Breast Cancer Resistant Protein / Mitoxantrone Updated

  2001influential reference
• Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse

  2001cited by this paper
• Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.

  2001cited by this paper
• X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy

  2001cited by this paper
• The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3

  2001cited by this paper
• JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome.

  2000cited by this paper
• Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody.

  1999cited by this paper
• Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity.

  1999cited by this paper
• Structural requirements for cellular uptake of alpha-helical amphipathic peptides.

  1999cited by this paper
• Structural requirements for cellular uptake of α‐helical amphipathic peptides

  1999cited by this paper
• The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product.

  1996cited by this paper
• X-linked lymphoreticular disease in the scurfy (sf) mutant mouse.

  1991cited by this paper
• Insights on the amino acid side-chain interactions of a synthetic T-cell determinant.

  1991cited by this paper

• Optimizing protocols for human regulatory T isolation, expansion, and characterization.

  2025cites this paper
• Treg Upregulation by Treadmill Training Accelerates Myelin Repair Post-Ischemia

  2025cites this paper
• Phosphatidylserine as a tumor target for CAR-T cell therapy

  2025cites this paper
• Identification of a group of 9-amino-acridines that selectively downregulate regulatory T cell functions through FoxP3

  2025cites this paper
• Induction of Regulatory T Cells After Virus Infection and Vaccination.

  2025cites this paper
• Lanatoside C activates the E3 ligase STUB1 to inhibit FOXP3 transcriptional activity and promote antitumor immunity

  2025cites this paper
• Targeting FOXP3 in glioblastoma: Blockade of tumor intrinsic effects boosts response to chemo-radiotherapy.

  2025cites this paper
• Spatial profiling of the mouse colonic immune landscape associated with colitis and sex

  2024cites this paper
• Discovery of a proteolysis targeting chimera (PROTAC) as a potent regulator of FOXP3.

  2024cites this paper
• The CCR6-CCL20 axis promotes regulatory T cell glycolysis and immunosuppression in tumors.

  2024cites this paper
• Foxp3 inhibitory peptide encapsulated in a novel CD25-targeted nanoliposome promotes efficient tumor regression in mice

  2024cites this paper
• Tethered IL15-IL15Rα augments antitumor activity of CD19 CAR-T cells but displays long-term toxicity in an immunocompetent lymphoma mouse model

  2024cites this paper
• Emerging roles of FOXK2 in cancers and metabolic disorders

  2024cites this paper
• Improving the efficacy of peptide vaccines in cancer immunotherapy.

  2023cites this paper
• Targeting FOXP3 Tumor-Intrinsic Effects Using Adenoviral Vectors in Experimental Breast Cancer

  2023influential citation
• Comparison of the inhibitory and stimulatory effects of Core and NS3 candidate HCV vaccines on the cellular immune response.

  2023cites this paper
• Cancer Vaccines in the Immunotherapy Era: Promise and Potential

  2023cites this paper
• The transcriptional regulator Sin3A balances IL‐17A and Foxp3 expression in primary CD4 T cells

  2023cites this paper
• Regulatory T Cell Inhibition by P60 Combined with Adenoviral AFP Transduced Dendritic Cells for Immunotherapy of Hepatocellular Carcinoma

  2023influential citation
• Improvement of cognitive function in wild-type and Alzheimer´s disease mouse models by the immunomodulatory properties of menthol inhalation or by depletion of T regulatory cells

  2023influential citation
• Stimulation of antitumor immunity by FoxP3-targeting PROTAC.

  2023cites this paper
• Immunogenic cell death inducer peptides: A new approach for cancer therapy, current status and future perspectives.

  2023cites this paper
• Drug conjugates for targeting regulatory T cells in the tumor microenvironment: guided missiles for cancer treatment

  2023cites this paper
• Overcoming T cell dysfunction in acidic pH to enhance adoptive T cell transfer immunotherapy

  2022cites this paper
• Impact of tumor microenvironment on adoptive T cell transfer activity.

  2022cites this paper
• Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells

  2022cites this paper
• The dark side of Tregs during aging

  2022cites this paper
• Inhibition of FOXP3 by stapled alpha-helical peptides dampens regulatory T cell function

  2022cites this paper
• Lymph node-targeted neoantigen nanovaccines potentiate anti-tumor immune responses of post-surgical melanoma

  2022cites this paper
• The transcriptional regulator Sin3A balances IL-17A and Foxp3 expression in primary CD4 T cells

  2022cites this paper
• Accumulation of pTreg cells is detrimental in late‐onset (aged) mouse model of multiple sclerosis

  2022cites this paper
• Progression on the Roles and Mechanisms of Tumor-Infiltrating T Lymphocytes in Patients With Hepatocellular Carcinoma

  2021cites this paper
• Bee venom phospholipase A2 alleviates collagen-induced polyarthritis by inducing Foxp3+ regulatory T cell polarization in mice

  2021cites this paper
• Protective immune response against P32 oncogenic peptide-pulsed PBMCs in mouse models of breast cancer.

  2021cites this paper
• Searching for Peptide Inhibitors of T Regulatory Cell Activity by Targeting Specific Domains of FOXP3 Transcription Factor

  2021cites this paper
• Thymic Aging May Be Associated with COVID-19 Pathophysiology in the Elderly

  2021cites this paper
• Foxp3 Silencing with Antisense Oligonucleotide Improves Immunogenicity of an Adjuvanted Recombinant Vaccine against Sporothrix schenckii

  2021cites this paper
• Regulatory T cells and vaccine effectiveness in older adults. Challenges and prospects.

  2021cites this paper
• The emerging role of transcription factor FOXP3 in thyroid cancer

  2021cites this paper
• Accumulation of Treg cells is detrimental in late-onset (aged) mouse model of multiple sclerosis

  2021cites this paper
• Genomics of FOXP3 Enhance Treg and Maintain Immune-homeostasis

  2021cites this paper
• Transcriptional Control of Regulatory T Cells in Cancer: Toward Therapeutic Targeting?

  2020cites this paper
• Clinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Renal Cell Carcinoma

  2020cites this paper
• Targeting Inhibition of Foxp3 by MMP2/9 Sensitive Short Peptide Linked P60 Fusion Protein 6(P60-MMPs) to Enhance Antitumor Immunity.

  2020cites this paper
• FOX transcription factor family in hepatocellular carcinoma.

  2020cites this paper
• In Silico Analysis of the FOXP3 Transcription Factor Associated with T-Cell Oncogenesis

  2020cites this paper
• Therapeutic peptides that immunoactivate the tumor microenvironment.

  2020influential citation
• Targeting FOXP3 complex ensemble in drug discovery.

  2020cites this paper
• Phage Display-Based Nanotechnology Applications in Cancer Immunotherapy

  2020cites this paper
• Nuclear FOXP3 inhibits tumor growth and induced apoptosis in hepatocellular carcinoma by targeting c-Myc

  2020cites this paper
• Downregulation of FOXP3 in neutrophils by IL-8 promotes the progression of oral squamous cell carcinoma

  2019influential citation
• An investigation into the phenotype, function and immunomodulatory properties of in vitro expanded iNKT cells

  2019cites this paper
• Recent advances with Treg depleting fusion protein toxins for cancer immunotherapy.

  2019cites this paper
• Genetic Modification of CD8+ T Cells to Express EGFR: Potential Application for Adoptive T Cell Therapies

  2019cites this paper
• Potential immunomodulatory effect of allelochemical juglone in mice vaccinated with BCG

  2019cites this paper
• FOXP3 Inhibitory Peptide P60 Increases Efficacy of Cytokine-induced Killer Cells Against Renal and Pancreatic Cancer Cells

  2019cites this paper
• Neoantigen vaccine: an emerging tumor immunotherapy

  2019cites this paper
• Tr1 cell immunotherapy promotes transplant tolerance via de novo Tr1 cell induction in mice and is safe and effective during acute viral infection

  2018cites this paper
• Combination Immunotherapy: Taking Cancer Vaccines to the Next Level

  2018influential citation
• Inhibition of Nr4a Receptors Enhances Antitumor Immunity by Breaking Treg-Mediated Immune Tolerance.

  2018cites this paper
• TGF-β1/Smad2/3/Foxp3 signaling is required for chronic stress-induced immune suppression.

  2018cites this paper
• Intratumoral Immunotherapy with XCL1 and sFlt3L Encoded in Recombinant Semliki Forest Virus-Derived Vectors Fosters Dendritic Cell-Mediated T-cell Cross-Priming.

  2018cites this paper
• Aptamer-iRNAs as Therapeutics for Cancer Treatment

  2018cites this paper
• Molecular adjuvants that modulate regulatory T cell function in vaccination: A critical appraisal

  2017cites this paper
• The Role of Regulatory T Cells and Indoleamine-2,3-Dioxygenase in Brain Tumor Immunosuppression

  2017cites this paper
• Aptamers as a Promising Therapeutic Tool for Cancer Immunotherapy

  2017influential citation
• FoxP3 Expression in Macrophages, Cancer, and B Cells—Is It Real?

  2017cites this paper
• Linear Peptides in Intracellular Applications.

  2017cites this paper
• Lenalidomide acts as an adjuvant for HCV DNA vaccine

  2017cites this paper
• Therapeutic blockade of Foxp3 in experimental breast cancer models

  2017cites this paper
• Emerging cancer-specific therapeutic aptamers

  2017cites this paper
• The importance of correctly timing cancer immunotherapy

  2017cites this paper
• Immunotherapy for the treatment of breast cancer

  2017cites this paper
• Lambda phage nanoparticles displaying HER2-derived E75 peptide induce effective E75-CD8+ T response

  2017cites this paper
• Blockage of FOXP3 transcription factor dimerization and FOXP3/AML1 interaction inhibits T regulatory cell activity: sequence optimization of a peptide inhibitor

  2017cites this paper
• Aptamers: A Feasible Technology in Cancer Immunotherapy

  2016influential citation
• Foxp3 enhances HIF-1α target gene expression in human bladder cancer through decreasing its ubiquitin-proteasomal degradation

  2016cites this paper
• Antitumor effect of an adeno-associated virus expressing apolipoprotein A-1 fused to interferon alpha in an interferon alpha-resistant murine tumor model

  2016cites this paper
• Targeting inhibition of Foxp3 by a CD28 2'-Fluro oligonucleotide aptamer conjugated to P60-peptide enhances active cancer immunotherapy.

  2016cites this paper
• Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion

  2016cites this paper
• Aptamers: A New Technological Platform in Cancer Immunotherapy

  2016influential citation
• Epirubicin, Identified Using a Novel Luciferase Reporter Assay for Foxp3 Inhibitors, Inhibits Regulatory T Cell Activity

  2016influential citation
• MRP1-CD28 bi-specific oligonucleotide aptamers: target costimulation to drug-resistant melanoma cancer stem cells

  2016cites this paper
• Reversal of Diabetes in NOD Mice by Clinical-Grade Proinsulin and IL-10–Secreting Lactococcus lactis in Combination With Low-Dose Anti-CD3 Depends on the Induction of Foxp3-Positive T Cells

  2016cites this paper
• How antigen specificity directs regulatory T‐cell function: self, foreign and engineered specificity

  2016cites this paper
• Lack of the protein tyrosine phosphatase PTPN22 strengthens transplant tolerance to pancreatic islets in mice

  2015cites this paper
• Molecular targets in arthritis and recent trends in nanotherapy

  2015cites this paper
• StimulationEnhances T Cell Function after TCR Inhibition of FOXP3/NFAT Interaction

  2015cites this paper
• Identification of small-molecule inhibitors of calcineurin-NFATc signaling that mimic the PxIxIT motif of calcineurin binding partners

  2015cites this paper
• Inhibition of FOXP3/NFAT Interaction Enhances T Cell Function after TCR Stimulation

  2015influential citation
• 2-fluoro-RNA oligonucleotide CD40 targeted aptamers for the control of B lymphoma and bone-marrow aplasia.

  2015cites this paper
• Foxp3 expression in T regulatory cells and other cell lineages

  2014cites this paper
• PLATELET-LYMPHOCYTE CROSS-TALK IN ATHEROGENESIS Experimental Studies on Platelet-Regulated Lymphocyte Adhesion and CD4 + T Cell Activation

  2014cites this paper
• The TRAF3 adaptor protein drives proliferation of anaplastic large cell lymphoma cells by regulating multiple signaling pathways

  2014cites this paper
• Immunosuppressive networks and checkpoints controlling antitumor immunity and their blockade in the development of cancer immunotherapeutics and vaccines

  2014cites this paper
• Transcriptional control of regulatory T cells.

  2014influential citation
• Optimizing Dendritic Cell-Based Approaches for Cancer Immunotherapy

  2014cites this paper
• Foxp3 expression in T regulatory cells and other cell lineages

  2014cites this paper
• Routing cancer immunology and immunotherapy from the lab to the clinic 4–5 th March 2014, Center for Applied Medical Research and University Clinic, Pamplona, Spain

  2014cites this paper
• Platelets provoke distinct dynamics of immune responses by differentially regulating CD4+ T‐cell proliferation

  2014cites this paper